Results 1 to 10 of about 55,757 (129)

Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle [PDF]

open access: gold, 2009
gamma-herpesvirus Epstein-Barr virus (EBV) persists for life in infected individuals despite the presence of a strong immune response. During the lytic cycle of EBV many viral proteins are expressed, potentially allowing virally infected cells to be ...
A Rickinson   +51 more
core   +25 more sources

Lytic Cycle ofToxoplasma gondii [PDF]

open access: bronzeMicrobiology and Molecular Biology Reviews, 2000
SUMMARYToxoplasma gondii is an obligate intracellular pathogen within the phylum Apicomplexa. This protozoan parasite is one of the most widespread, with a broad host range including many birds and mammals and a geographic range that is nearly worldwide.
Michael W. Black, John C. Boothroyd
openalex   +4 more sources

The Induction of the Lytic Cycle in Lysogenic Bacteria by Phagolessin A 58 [PDF]

open access: bronzeJournal of General Microbiology, 1956
SUMMARY: Phagolessin A58, an antibiotic having antiphage activity, was found to have an action which induced the lytic cycle in some strains of lysogenic bacteria. Four different lysogenic organisms were tested: Bacillus megaterium 899; Escherichia coli FCb; E. coli Temple; E. coli Lampert.
E. Hall-Asheshov, Igor N. Asheshov
openalex   +4 more sources

Mitochondrial behaviour throughout the lytic cycle of Toxoplasma gondii [PDF]

open access: yesScientific Reports, 2017
Mitochondria distribution in cells controls cellular physiology in health and disease. Here we describe the mitochondrial morphology and positioning found in the different stages of the lytic cycle of the eukaryotic single-cell parasite Toxoplasma gondii.
Lemgruber, Leandro   +4 more
core   +6 more sources

The activation of KSHV lytic cycle blocks autophagy in PEL cells [PDF]

open access: yesAutophagy, 2015
This study confirms that autophagy is activated concomitantly with KSHV lytic cycle induction, and that autophagy inhibition by BECN1 knockdown reduces viral lytic gene expression.
CIRONE, Mara   +7 more
core   +5 more sources

Contribution of the KSHV and EBV lytic cycles to tumourigenesis [PDF]

open access: hybridCurrent Opinion in Virology, 2018
Kaposi's Sarcoma-associated herpesvirus (KSHV) and Epstein Barr virus (EBV) are the causative agents of several malignancies. Like all herpesviruses, KSHV and EBV undergo distinct latent and lytic replication programmes. The transition between these states allows the establishment of a lifelong persistent infection, dissemination to sites of disease ...
Oliver Manners   +4 more
openalex   +5 more sources

Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency [PDF]

open access: green, 2000
Herpesviruses are characterized as having two distinct life cycle phases: lytic replication and latency. The mechanisms of latency establishment and maintenance, as well as the switch from latency to lytic replication, are poorly understood.
Nash, A A   +4 more
core   +3 more sources

ARID3B: A novel regulator of the Kaposi's sarcoma-associated herpesvirus lytic cycle [PDF]

open access: yesJournal of Virology, 2016
Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of commonly fatal malignancies of immunocompromised individuals, including primary effusion lymphoma (PEL) and Kaposi's sarcoma (KS).
Boyne, JR   +6 more
core   +8 more sources

Herpesvirus Lytic Replication and the Cell Cycle: Arresting New Developments [PDF]

open access: greenJournal of Virology, 2001
It has been clear for a number of years that small DNA tumor viruses such as simian virus 40 (SV40) and papillomavirus interact with cell cycle control pathways during lytic replication in a way that promotes entry into the S phase of the cell cycle.
Erik K. Flemington
openalex   +3 more sources

Lytic cycle: A defining process in oncolytic virotherapy [PDF]

open access: yesApplied Mathematical Modelling, 2013
The viral lytic cycle is an important process in oncolytic virotherapy. Most mathematical models for oncolytic virotherapy do not incorporate this process.
Tian, Jianjun Paul   +3 more
core   +4 more sources

Home - About - Disclaimer - Privacy